H.R. 3631
VITAL Act of 2025
Sponsor: Mark E. Green · 0 cosponsors
Official summary
No official summary yet.
Text of the bill
Section 564(g)(2) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–3(g)(2)) is amended—
(1) in subparagraph (B), by striking or at the end;
(2) by redesignating subparagraph (C) as subparagraph (D); and
(3) by inserting after subparagraph (B) the following:
(C) the Secretary determines that fraudulent material statements were made, or material information was concealed, with respect to the circumstances described under subsection (b)(1) or the criteria under subsection (c); or